+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Worldwide Insulin Pump Market - Drivers, Opportunities, Trends, and Forecasts: 2017-2023

  • ID: 4368437
  • Report
  • June 2017
  • Region: Global
  • 92 pages
  • Infoholic Research LLP


  • Abbott Laboratories
  • Animas Corp.
  • B. Braun Melsungen AG
  • Carestream Health Inc.
  • F.Hoffmann-La Roche Ltd
  • Insulet Corp.
  • MORE
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

Worldwide Insulin Pumps Market - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017-2023


Insulin pump is a small and discreet device that delivers a specific amount of insulin through a needle inserted underneath the skin. The insulin pump is integrated with the receiver, transmitter, and a sensor that can be programmed to deliver constant doses of insulin during the day. It delivers and regulates blood sugar level in the body. It consists of a disposable infusion set, a cannula for subcutaneous insertion, a tubing system to connect the cannula with the insulin reservoir, and a disposable reservoir for insulin set.

Factors such as rising prevalence of diabetic patients, technological advancements, and the increasing potential in the emerging countries are expected to drive the market growth during the forecast period. The high cost of insulin pumps and stringent regulatory approval process are factors hampering the market growth.

The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period due to the high prevalence of diabetes in these countries.

Market Analysis:

The global insulin pumps market is estimated to witness a CAGR of 8.3% during the forecast period 2017-2023. The market is analyzed based on three segments - product types, end-users, and regions.

The factors such as re-sales of insulin pumps and the increased adoption of advanced technology products are the opportunities for the market players during the forecast period. Increasing awareness among people about diabetes and glucose monitoring devices has a significant impact on the growth of the global insulin pumps market.

Product Analysis:

The market is witnessing an emerging trend for advanced insulin pumps such as Medtronic's MiniMed 530G system. Knowledge about the advantages of insulin pumps systems over traditional injections, meters, and other glucose monitors has led to the market growth in developed countries.

The regulatory scenario is of concern as there has been a wide range of instruments and assays, which range from Class I to Class III devices. Recently, there has been a change in regulations in the European region, which has become a major issue for the market players.

Regional Analysis:

The regions covered in the report are the Americas, EMEA, APAC, and Rest of the World (ROW). The Americas is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The markets in India, Brazil, and China are expected to grow at a rapid pace during the forecast period as the prevalence of diabetes and lifestyle diseases in these countries is high. These countries are set to be the target regions for the players due to the large untapped market.

Key Players:

The leader in the insulin pumps market is Animas, who is currently occupying the majority of the insulin pumps market share. Medtronic, Roche, Asante, Cellnovo, and Insulet are the other major players in the market. These top players occupy more than half of the market.

The report covers the following players:

  • Animus Corp.
  • Medtronics Inc.
  • Insulet Corp.
  • Roche Diagnostics
  • Cellnovo Ltd.
  • Asante
  • Nipro Diagnostic Inc.
  • Tandem Diabetes Care Inc.
  • Sooil Development Co. Ltd.
  • Ypsomed

Competitive Analysis:

The tethered pumps segment is dominating the global insulin pumps market, and a lot of new players are focusing on developing technologically advanced reagents and analyzers to gain the market share. The advanced products such as MiniMed 530G system and OmniPod insulin pumps are expected to drive the market growth in the future.

The large players such as F. Hoffmann-La Roche and Medtronics are acquiring companies with products that would complement their existing portfolio. Significant investments in R&D in this market is expected to increase, and collaborations and M&A are expected to continue.


The report provides complete details about the usage and the adoption rate of insulin pumps by various end-users and regions. The key stakeholders use this information to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the increasing awareness of diseases in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report provides complete details about the main business opportunities to the key stakeholders to expand their business and gain revenue in the specific vertical and to analyze before investing or expanding the business in this market.

Note: Product cover images may vary from those shown


  • Abbott Laboratories
  • Animas Corp.
  • B. Braun Melsungen AG
  • Carestream Health Inc.
  • F.Hoffmann-La Roche Ltd
  • Insulet Corp.
  • MORE

1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 Pest Analysis

2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Infusion Pumps Market
3.3.2 Diabetes Drugs Market
3.3.3 Diabetes Management Market

4 Market Outlook
4.1 Overview
4.2 Market Definition
4.3 Importance of Insulin Pumps
4.4 Market Segmentation
4.5 Porter 5(Five) Forces

5 Market Characteristics
5.1 Evolution
5.2 Insulin Pumps Advantages
5.3 Insulin Pumps Disadvantages
5.4 Role of Insulin Pumps in Healthcare
5.5 Market Dynamics
5.5.1 Drivers Potential increase in the number of aged population Growing awareness of insulin pumps in the emerging markets Significant focus on diabetes management Increasing prevalence of diabetic population
5.5.2 Opportunities Substitute for conventional diabetes treatments Technological advancements Significant increase in the number of mergers and acquisitions Latest product launches
5.5.3 Restraints Threat of technological substitutes Unfavorable reimbursement plans Acute competition in the market Issues related to product pricing
5.5.4 DRO - Impact Analysis
5.5.5 Key Stakeholders

6 Types: Market Size and Analysis
6.1 Overview
6.2 Tethered Pumps
6.3 Untethered Pumps
6.4 Implantable Pumps

7 End User: Market Size and Analysis
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Care
7.4 Others

8 Regions: Market Size and Analysis
8.1 Overview
8.2 Americas
8.3 EMEA
8.4 APAC

9 Market Attractiveness
9.1 Market Attractiveness by Types
9.2 Market Attractiveness by End Users

10 Competitive Landscape
10.1 Overview

11 Vendor Profiles
11.1 Animas Corp.
11.1.1 Overview
11.1.2 Business Focus
11.1.3 Business Strategy
11.2 Insulet Corp.
11.2.1 Overview
11.2.2 Business Unit
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategy
11.3 Medtronic Plc
11.3.1 Overview
11.3.2 Business Unit
11.3.3 Geographic Presence
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategy
11.4 F.Hoffmann-La Roche Ltd
11.4.1 Overview
11.4.2 Business Unit
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategy
11.5 Abbott Laboratories
11.5.1 Overview
11.5.2 Business Unit
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategy

12 Companies to Watch For
12.1 Sanofi
12.1.1 Overview
12.1.2 Sanofi in 2015
12.2 B. Braun Melsungen AG
12.2.1 Overview
12.3 Carestream Health Inc.
12.3.1 Overview
12.4 Abbreviations

Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Animas Corp.
  • B. Braun Melsungen AG
  • Carestream Health Inc.
  • F.Hoffmann-La Roche Ltd
  • Insulet Corp.
  • Medtronic Plc
  • Sanofi
Note: Product cover images may vary from those shown